Document is current
Any future updates will be listed below
-
Authors
Perkins, Daniel https://orcid.org/0000-0002-2055-1649
Halman, Andreas https://orcid.org/0000-0001-5248-4121
Urokohara, Anna https://orcid.org/0009-0004-6960-0327
Palumbo, Joeseph
Low, Mitchell https://orcid.org/0000-0003-2021-1924
Ruffell, Simon https://orcid.org/0000-0002-8250-4426
Galvão-Coelho, Nicole https://orcid.org/0000-0002-4887-8635
Collins, Lisa https://orcid.org/0000-0003-0308-4214
Norman, Amanda https://orcid.org/0000-0002-5183-1192
Sarris, Jerome https://orcid.org/0000-0001-9287-8854
-
Funding
Funding for this research was provided by:
Neurala Biosciencess
Neurala Biosciences
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 24 October 2025
First Online: 20 November 2025
Declarations
:
: DP and JS are employed by and hold equity in Neurala Biosciences, which is undertaking research with psychedelic compounds. AU and JP are engaged in paid staff roles in the same organisation. ML also holds equity in Neurala Biosciences. AH, SR, NGC, LC and AN do not have competing interests.
